Safety and Efficacy of QAX576 in Patients With Progressive Idiopathic Pulmonary Fibrosis (IPF)

Update Il y a 4 ans
Reference: EUCTR2010-020688-18

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

• To evaluate the safety and tolerability of multiple intravenous dosing of QAX576 in patients with IPF • To evaluate the effect of multiple intravenous dosing of QAX576 on lung function assessed by FVC at 1 year as compared to baseline


Inclusion criteria

  • Patients with rapidly progressive idiopathic pulmonary fibrosis

Links